Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure. - Wikidata - awgldk - TriplyDB

Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure.

Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure.

http://www.wikidata.org/entity/Q37365585

about

Cellular phenotype and extracellular vesicles: basic and clinical considerations.Perspectives on the Potential Therapeutic Uses of Vesicles.Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy.Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation Quantitative proteome analysis of colorectal cancer-related differential proteins.Extracellular vesicles in prostate cancer: new future clinical strategies?Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer.Extracellular RNA mediates and marks cancer progression.Proteomics of cell-cell interactions in health and disease.Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles.Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management.Systems pharmacology using mass spectrometry identifies critical response nodes in prostate cancer.Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond Circular RNA: new star, new hope in cancer

P2860

Q33788880-F5A20B41-D090-4AB1-9DD6-49461E20741E Q35632958-9624CEC0-4242-4D19-B505-20203641D717 Q35732325-691D2A4C-1C75-4F80-987B-577D386CFB80 Q35807725-C0CF0AE6-D4F2-4856-9894-73788ABE1C1C Q35878477-282F8AA4-16EE-43D2-A704-8747465A342B Q36142004-3D8CE940-EEB3-469A-A120-57E3252156CE Q37632337-F8F4CEC9-D89B-40C7-AE38-328AF851DEFA Q37673863-58B4D40D-FF51-482D-8342-6586AEBBA555 Q38208372-D614434B-0500-4466-A395-C8E18DAEDFBD Q38629150-8DEBFC0A-CC9C-4DD3-A9EB-3F98BA1FC76F Q38694648-BA4D95E3-B713-4F02-A08F-D91AB814C0CC Q55342189-BD1CB92F-2DE9-4E60-9963-1E84981B1C76 Q55447045-63A7D9E4-8E96-4EA9-8B2A-9EE61801E41A Q58722406-39E5F683-8D3F-4241-B475-5CE26843AE09 Q58736691-E32C9B68-E9B3-43B0-A80F-EA027C19C107

P2860

Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure.

http://www.wikidata.org/entity/Q37365585

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reversal of chemosensitivity a ...... xtracellular vesicle exposure.

@en

Reversal of chemosensitivity a ...... xtracellular vesicle exposure.

@nl

type

label

Reversal of chemosensitivity a ...... xtracellular vesicle exposure.

@en

Reversal of chemosensitivity a ...... xtracellular vesicle exposure.

@nl

prefLabel

Reversal of chemosensitivity a ...... xtracellular vesicle exposure.

@en

Reversal of chemosensitivity a ...... xtracellular vesicle exposure.

@nl

P1433

Q37365585-942FBEA3-B703-4801-9CC9-60DE6D6C9FF3

P1476

Q37365585-AF72BBF6-30BE-4CDD-92FB-9804DFBAA031

P2093

Q37365585-06F24DC4-9D07-4F20-85A8-840A79EF19F9

Q37365585-33743106-72FE-4A9B-9433-84F43FFE8EB9

Q37365585-344CC190-1DC6-431C-A0CC-735C68806D58

Q37365585-3BDB1633-9843-4813-8727-390AE4751C72

Q37365585-5A8E0E05-5192-4F72-A60D-F9C0FBF68E79

Q37365585-6BD93EE1-1CDB-4187-A81B-AB023995F10C

Q37365585-AC357B63-C288-413C-AB1E-6F8B8033F75D

Q37365585-E9BE9FBC-FA99-4B45-91FE-28AC5CF2573F

Q37365585-F32E0A11-4400-4EA3-A6B9-D1E2BD6A1078

P2860

Q37365585-03F37685-FACA-4C85-90EE-BDB300F702F3

Q37365585-07B788F6-3D05-4605-A941-74336CBE0028

Q37365585-126BFAFC-9D72-48EA-8D3E-43BD1E484B45

Q37365585-1BC21521-EF87-409B-A817-D2794371F779

Q37365585-1CC2730A-37CE-4F59-80C8-B6E15C3B257C

Q37365585-1F17C6B2-3695-462D-9270-56AAC8A77E62

Q37365585-1FD1658B-B636-465A-9B05-C1D9533C2246

Q37365585-24FC6001-642E-4787-AA41-2FE42E1F26B4

Q37365585-251BCC58-BECE-4CDF-8043-89E94D89171F

Q37365585-2A9EFCA9-B50B-4869-BBE8-D0BCD546D52A

P2888

Q37365585-AFB28FFD-72DB-4BAC-A98C-349C20B2401A

P304

Q37365585-991AFED5-E44C-44F3-940B-F37D904EB6C2

P31

Q37365585-78637A77-9099-4490-8CD8-257F28C95530

P356

Q37365585-DACE2141-39D7-4587-B3FE-1AE2BA37CF53

P433

Q37365585-94A9F669-7B69-4DED-B6C1-45A133234FB2

P478

Q37365585-1B8D99AF-56FE-4BEF-8F80-B9866D6BD219

P50

Q37365585-2F48707F-44BE-4820-A1EB-D8F3297E1FA5

P577

Q37365585-9351D540-0A3D-4B37-B2B8-C3EB936DFC22

P5875

Q37365585-BF60A051-1838-4437-89DE-468DE6A82B92

P6179

Q37365585-591D7CF6-3C33-4597-9390-903EC683C2FF

P698

Q37365585-18275087-06EF-4EBA-B124-B0F1AD517A49

P921

Q37365585-57AE506F-195D-4C20-9042-A97AFE76ED8E

P932

Q37365585-E7596A1B-F5F8-4379-9A82-0C264608FEDD

P356

1476-4598-12-118

P1433

Molecular Cancer

P1476

Reversal of chemosensitivity a ...... xtracellular vesicle exposure.

@en

P2093

Christen Dillard

http://www.w3.org/2001/XMLSchema#string

David Mills

http://www.w3.org/2001/XMLSchema#string

Devasis Chatterjee

http://www.w3.org/2001/XMLSchema#string

Joseph Renzulli

http://www.w3.org/2001/XMLSchema#string

Kiriaki Panagopoulos

http://www.w3.org/2001/XMLSchema#string

Lisa Goldstein

http://www.w3.org/2001/XMLSchema#string

Michael Del Tatto

http://www.w3.org/2001/XMLSchema#string

Peter Quesenberry

http://www.w3.org/2001/XMLSchema#string

Sam Cross-Knorr

http://www.w3.org/2001/XMLSchema#string

P2860

Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling

Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation

Regulation of RAF activity by 14-3-3 proteins: RAF kinases associate functionally with both homo- and heterodimeric forms of 14-3-3 proteins

Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals

Microvesicles: mediators of extracellular communication during cancer progression

Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.

Exosomes: from biogenesis and secretion to biological function

Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease

Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.

Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis

P2888

1476-4598-12-118

P304

118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-12-118

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Dionysios Pantazatos

P577

2013-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257533250

http://www.w3.org/2001/XMLSchema#string

P6179

1031318646

http://www.w3.org/2001/XMLSchema#string

P698

24103426

http://www.w3.org/2001/XMLSchema#string

P921

P932

3851868

http://www.w3.org/2001/XMLSchema#string